BioHorizons, which sells dental implants and related products, has withdrawn its plans for an initial public offering (IPO), citing poor market conditions.
The company originally announced the proposed $90 million IPO in January 2011 but postponed the deal less than a month later.
In addition to dental implants, BioHorizons manufactures tissue-regeneration products for the replacement of missing teeth. Its implant products are based on a proprietary Laser-Lok platform technology and biomechanically engineered threads.
.DpIowD0Qsf.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
